The impact of baseline body mass index on clinical outcomes in metastatic breast cancer: a prospective study
Abstract Objective The prognostic value of body mass index (BMI) in metastatic breast cancer (MBC) has not been fully elucidated. In a prospective study to investigate the chemo-sensitizing effect of statins on clinical outcomes in MBC patients who were scheduled to receive palliative chemotherapy (...
Main Authors: | Hiba Alarfi, Maher Salamoon, Mohammad Kadri, Moosheer Alammar, Mhd Adel Haykal, Alhadi Alseoudi, Lama A. Youssef |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-017-2876-2 |
Similar Items
-
Impact of Body Mass Index on Survival of Metastatic Renal Cancer
by: Jose Javier Salgado, et al.
Published: (2021-07-01) -
Impact of body mass index on clinico-pathological parameters and outcome in patients with metastatic prostate cancer
by: Amrallah A. Mohammed, et al.
Published: (2015-09-01) -
Impact of body mass index on overall survival in patients with metastatic breast cancer
by: Khalil Saleh, et al.
Published: (2021-02-01) -
OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan N. Davidov
Published: (2013-12-01) -
Primary tumor resection benefited the survival of patients with distant metastatic gastric cancer
by: Yan Gao, et al.
Published: (2021-01-01)